Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up

To determine the natural history of imaging findings seen on magnetic resonance imaging (MRI) of hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT). Although arterial hyperenhancement is a key feature of untreated HCC, our clinical experience suggested that tumors that never progressed could still show hyperenhancement. Therefore, we undertook a systematic study to test the hypothesis that persistent arterial phase hyperenhancement (APHE) after SBRT is an expected finding that does not suggest failure of treatment.

Source: International Journal of Radiation Oncology * Biology * Physics - September 10, 2018 Category: Radiology Authors: Mishal Mendiratta-Lala, William Masch, Prasad R. Shankar, Holly E. Hartman, Matthew S. Davenport, Matthew J. Schipper, Chris Maurino, Kyle C. Cuneo, Theodore S. Lawrence, Dawn Owen Tags: Clinical Investigation Source Type: research